ARIAD Pharmaceuticals (ARIA)

Add to Watchlists
Create an Alert
8.21 +0.18  +2.24% NASDAQ May 27, 20:00 Delayed 2m USD

ARIAD Pharmaceuticals Enterprise Value:

1.864B for May 27, 2016
View 4,000+ financial data types
Browse...
View Full Chart

ARIAD Pharmaceuticals Enterprise Value Chart

Export Data
Save Image

ARIAD Pharmaceuticals Historical Enterprise Value Data

View and export this data going back to 1994. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
May 27, 2016 1.864B
May 26, 2016 1.829B
May 25, 2016 1.852B
May 24, 2016 1.818B
May 23, 2016 1.839B
May 20, 2016 1.776B
May 19, 2016 1.759B
May 18, 2016 1.795B
May 17, 2016 1.768B
May 16, 2016 1.774B
May 13, 2016 1.724B
May 12, 2016 1.711B
May 11, 2016 1.728B
May 10, 2016 1.755B
May 9, 2016 1.667B
May 6, 2016 1.629B
May 5, 2016 1.581B
May 4, 2016 1.565B
May 3, 2016 1.638B
May 2, 2016 1.690B
April 29, 2016 1.665B
April 28, 2016 1.664B
April 27, 2016 1.673B
April 26, 2016 1.679B
April 25, 2016 1.700B
   
April 22, 2016 1.700B
April 21, 2016 1.717B
April 20, 2016 1.685B
April 19, 2016 1.665B
April 18, 2016 1.673B
April 15, 2016 1.650B
April 14, 2016 1.591B
April 13, 2016 1.534B
April 12, 2016 1.518B
April 11, 2016 1.505B
April 8, 2016 1.555B
April 7, 2016 1.591B
April 6, 2016 1.545B
April 5, 2016 1.539B
April 4, 2016 1.515B
April 1, 2016 1.501B
March 31, 2016 1.515B
March 30, 2016 1.380B
March 29, 2016 1.372B
March 28, 2016 1.346B
March 24, 2016 1.446B
March 23, 2016 1.405B
March 22, 2016 1.467B
March 21, 2016 1.431B
March 18, 2016 1.393B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Enterprise Value

Click "Learn More" below to see how YCharts calculates Enterprise Value.

Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More

Advertisement

ARIA Enterprise Value Benchmarks

Companies
Acorda Therapeutics 1.120B
Cambrex 1.471B
Halozyme Therapeutics 1.249B

ARIA Enterprise Value Range, Past 5 Years

Minimum 123.63M Oct 31 2013
Maximum 3.996B Oct 05 2012
Average 1.833B

ARIA Enterprise Value Excel Add-In Codes

  • Metric Code: enterprise_value
  • Latest data point: =YCP("ARIA", "enterprise_value")
  • Last 5 data points: =YCS("ARIA", "enterprise_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.